Notice: Trying to get property 'slug' of non-object in /home/sgumdev/public_html/wp-content/themes/sgum_2016/single.php on line 44

written by reader icells

By davidmasson, June 2, 2015

from stephan petranek of Breakthrough Tecnology Alert

a tech company about to increase 1,700 % over a few years for a new cancer cure.

anyone know about this stock and him in general?
thanks,
david

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

7 Comments
Inline Feedbacks
View all comments
modernrock
7 years ago

I believe that one is BTX

👍 236
conwayed
conwayed
7 years ago
Reply to  modernrock

I think it’s probably Kite Pharma (KITE).

👍 26
modernrock
7 years ago
Reply to  conwayed

You are probably right, I got the wrong disease.

👍 236
SoGiAm
7 years ago

BTX-Jefferies presentation today: subsequent archived replay of the presentation will be accessible at http://wsw.com/webcast/jeff88/btx. The replay will be available for approximately 90 days after the event. Best2ALL!-Benjamin

👍 11466
jfenlin
jfenlin
7 years ago

I’m not sure it is either KITE or BTX, but KITE is more likely, as these teases sometimes twist reality, I just can’t find a perfect fit.

👍 11
jfenlin
jfenlin
7 years ago

Yeah probably KITE, his implied IRR (return adjusted for time) assumptions are silly if this is the one. Great innovative company but I have other immunotherapy plays with better risk/reward. Might use some cheap (for now) margin money to roll covered calls. Don’t mind leaving something on the table on this one. A very good company but the tease is quite misleading IF this is the one.

Add a Topic
5187
👍 11
jfenlin
jfenlin
7 years ago

I have looked at everything I can think of and this has to be KITE.
When I have time I’ll share what I View as misleading aspects of the Tease.
I do have a very small position in KITE, like it a little better than Juno (due to mkt caps) But am a raging long-term bull on SRNE and find ADXS very interesting with a totally differentiated immunotherapy approach, with super people and partners.

Add a Topic
5187
👍 11